The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCA BIOPHARMA INC | COM | 00211Y506 | 1,435,068 | 706,930 | SH | SOLE | 0 | 0 | 706,930 | |||
| ABERCROMBIE & FITCH CO | CL A | 002896207 | 4,427,400 | 117,500 | SH | SOLE | 0 | 0 | 117,500 | |||
| INVIVYD INC | COM | 00534A102 | 141,431 | 134,696 | SH | SOLE | 0 | 0 | 134,696 | |||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 8,199,915 | 5,157,179 | SH | SOLE | 0 | 0 | 5,157,179 | |||
| ASTROTECH CORP | COM | 046484309 | 3,121,006 | 220,410 | SH | SOLE | 0 | 0 | 220,410 | |||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 8,363,534 | 2,236,239 | SH | SOLE | 0 | 0 | 2,236,239 | |||
| ATHIRA PHARMA INC | COM | 04746L104 | 5,501,476 | 1,864,907 | SH | SOLE | 0 | 0 | 1,864,907 | |||
| AVROBIO INC | COM | 05455M100 | 243,489 | 256,277 | SH | SOLE | 0 | 0 | 256,277 | |||
| LISATA THERAPEUTICS INC | COM | 128058302 | 902,204 | 243,839 | SH | SOLE | 0 | 0 | 243,839 | |||
| QUINCE THERAPEUTICS INC | COM | 22053A107 | 2,124,818 | 1,411,839 | SH | SOLE | 0 | 0 | 1,411,839 | |||
| CYTEIR THERAPEUTICS INC | COM | 23284P103 | 8,450,000 | 3,250,000 | SH | SOLE | 0 | 0 | 3,250,000 | |||
| ELIEM THERAPEUTICS INC | COM | 28658R106 | 4,432,876 | 1,583,170 | SH | SOLE | 0 | 0 | 1,583,170 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 1,515,075 | 74,232 | SH | SOLE | 0 | 0 | 74,232 | |||
| FORTE BIOSCIENCES INC | COM | 34962G109 | 1,804,478 | 1,735,075 | SH | SOLE | 0 | 0 | 1,735,075 | |||
| GRAPHITE BIO INC | COM | 38870X104 | 395,957 | 152,291 | SH | SOLE | 0 | 0 | 152,291 | |||
| CALCIMEDICA INC | COM NEW | 38942Q202 | 356,012 | 88,781 | SH | SOLE | 0 | 0 | 88,781 | |||
| ISHARES TR | 0-3 MNTH TREASRY | 46436E718 | 18,113,400 | 180,000 | SH | SOLE | 0 | 0 | 180,000 | |||
| MEI PHARMA INC | COM | 55279B301 | 151,116 | 22,966 | SH | SOLE | 0 | 0 | 22,966 | |||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 776,625 | 272,500 | SH | SOLE | 0 | 0 | 272,500 | |||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 19,712 | 23,749 | SH | SOLE | 0 | 0 | 23,749 | |||
| NEXTCURE INC | COM | 65343E108 | 551,637 | 306,465 | SH | SOLE | 0 | 0 | 306,465 | |||
| ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 3,043,000 | 850,000 | SH | SOLE | 0 | 0 | 850,000 | |||
| PARDES BIOSCIENCES INC | COM | 69945Q105 | 6,862,856 | 3,791,633 | SH | SOLE | 0 | 0 | 3,791,633 | |||
| PASSAGE BIO INC | COM | 702712100 | 1,937,917 | 2,058,767 | SH | SOLE | 0 | 0 | 2,058,767 | |||
| RAIN ONCOLOGY INC | COM | 75082Q105 | 87,511 | 72,926 | SH | SOLE | 0 | 0 | 72,926 | |||
| RETRACTABLE TECHNOLOGIES INC | COM | 76129W105 | 768,861 | 668,575 | SH | SOLE | 0 | 0 | 668,575 | |||
| SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | 18,364,000 | 200,000 | SH | SOLE | 0 | 0 | 200,000 | |||
| SURROZEN INC | COM | 86889P109 | 802,496 | 1,459,084 | SH | SOLE | 0 | 0 | 1,459,084 | |||
| TALARIS THERAPEUTICS INC | COM | 87410C104 | 6,080,000 | 2,000,000 | SH | SOLE | 0 | 0 | 2,000,000 | |||
| TILLYS INC | CL A | 886885102 | 1,335,531 | 190,518 | SH | SOLE | 0 | 0 | 190,518 | |||
| VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 865,500 | 150,000 | SH | SOLE | 0 | 0 | 150,000 | |||